Valion Bio (VBIO) Gross Profit (2021 - 2026)
Valion Bio (VBIO) posted Gross Profit of -$45000.0 for Q2 2026, down 161.64% on a QoQ basis from $73000.0 in Q4 2025, and down 183.33% year-over-year from $54000.0 in Q2 2025.
Powered by 
Analysis
Valion Bio (VBIO) Gross Profit (2021 - 2026) Analysis & Trends
Valion Bio has reported Gross Profit for 6 years, with the latest figure at -$45000.0 in Q2 2026.
- On a quarterly basis, Gross Profit fell 183.33% year-over-year to -$45000.0 in Q2 2026; TTM through Jun 2026 was -$63000.0, a 30.77% increase from a year earlier, with the FY2025 full-year figure at $32000.0, up 1500.0% from the prior year.
- Gross Profit was -$45000.0 for Q2 2026 at Valion Bio, down from $73000.0 in the prior quarter.
- The five-year high for Gross Profit was $167000.0 in Q1 2024, with the low at -$239000.0 in Q4 2024.
- Average Gross Profit over 5 years is $33941.2, with a median of $54000.0 recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: Gross Profit soared 2250.0% in 2022, then sank 4880.0% in 2024.
- Over 5 years, Gross Profit stood at $43000.0 in 2022, then slumped by 88.37% to $5000.0 in 2023, then tumbled by 4880.0% to -$239000.0 in 2024, then surged by 130.54% to $73000.0 in 2025, then sank by 161.64% to -$45000.0 in 2026.
- The last three Gross Profit figures came in at -$45000.0 (Q2 2026), $73000.0 (Q4 2025), and -$145000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Valion Bio | 298,792.01 | -1.90 Mn | -45,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45,000.00 |
| Dec 31, 2025 | 73,000.00 |
| Sep 30, 2025 | -145,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | -239,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 167,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 108,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | 63,000.00 |
| Jun 30, 2022 | 125,000.00 |
| Mar 31, 2022 | 70,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -26,000.00 |
| Jun 30, 2021 | -33,000.00 |